Works by van Dam, Ellen

Results: 19

Identification and Characterisation of the RalA-ERp57 Interaction: Evidence for GDI Activity of ERp57.

Published in:

PLoS ONE, 2012, v. 7, n. 11, p. 1, doi. 10.1371/journal.pone.0050879

By:

Brymora, Adam;
Duggin, Iain G.;
Berven, Leise A.;
van Dam, Ellen M.;
Roufogalis, Basil D.;
Robinson, Phillip J.

Publication type:

Article

45-Hour continuous quintuple-site actimetry: Relations between trunk and limb movements and effects of circadian sleep-wake rhythmicity.

Published in:

Psychophysiology, 1997, v. 34, n. 2, p. 199, doi. 10.1111/j.1469-8986.1997.tb02132.x

By:

Middelkoop, Huub A. M.;
van Dam, Ellen M.;
Smilde-Van Den Doel, Dini A.;
van Dijk, Gert

Publication type:

Article

Therapeutic Efficacy of a Bivalent Inhibitor of Prostate-Specific Membrane Antigen Labeled with 67Cu.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 829, doi. 10.2967/jnumed.120.251579

By:

McInnes, Lachlan E.;
Cullinane, Carleen;
Roselt, Peter D.;
Jackson, Susan;
Blyth, Benjamin J.;
van Dam, Ellen M.;
Zia, Nicholas A.;
Harris, Matthew J.;
Hicks, Rodney J.;
Donnelly, Paul S.

Publication type:

Article

Therapeutic Efficacy of a Bivalent Inhibitor of Prostate-Specific Membrane Antigen Labeled with Copper-67.

Published in:

Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.251579

By:

McInnes, Lachlan E.;
Cullinane, Carleen;
Roselt, Peter D.;
Jackson, Susan;
Blyth, Benjamin J.;
van Dam, Ellen M.;
Zia, Nicholas A.;
Harris, Matthew J.;
Hicks, Rodney J.;
Donnelly, Paul S.

Publication type:

Article

Peptide Receptor Radionuclide Therapy with 67Cu-CuSarTATE is Highly Efficacious Against a Somatostatin Positive Neuroendocrine Tumor Model.

Published in:

Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.243543

By:

Cullinane, Carleen;
Jeffery, Charmaine M.;
Roselt, Peter D.;
van Dam, Ellen M.;
Jackson, Susan;
Kuan, Kevin;
Jackson, Price;
Binns, David;
van Zuylekom, Jessica;
Harris, Matthew J.;
Hicks, Rodney J.;
Donnelly, Paul S.

Publication type:

Article

Therapeutic Efficacy of a Bivalent Inhibitor of Prostate-Specific Membrane Antigen Labeled with Copper-67.

Published in:

Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.120.251579

By:

McInnes, Lachlan E.;
Cullinane, Carleen;
Roselt, Peter D.;
Jackson, Susan;
Blyth, Benjamin J.;
van Dam, Ellen M.;
Zia, Nicholas A.;
Harris, Matthew J.;
Hicks, Rodney J.;
Donnelly, Paul S.

Publication type:

Article

Peptide Receptor Radionuclide Therapy with 67Cu-CuSarTATE is Highly Efficacious Against a Somatostatin Positive Neuroendocrine Tumor Model.

Published in:

Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.120.243543

By:

Cullinane, Carleen;
Jeffery, Charmaine M.;
Roselt, Peter D.;
van Dam, Ellen M.;
Jackson, Susan;
Kuan, Kevin;
Jackson, Price;
Binns, David;
van Zuylekom, Jessica;
Harris, Matthew J.;
Hicks, Rodney J.;
Donnelly, Paul S.

Publication type:

Article

Therapeutic Efficacy of a Bivalent Inhibitor of Prostate-Specific Membrane Antigen Labeled with Copper-67.

Published in:

Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.120.251579

By:

McInnes, Lachlan E.;
Cullinane, Carleen;
Roselt, Peter D.;
Jackson, Susan;
Blyth, Benjamin J.;
van Dam, Ellen M.;
Zia, Nicholas A.;
Harris, Matthew J.;
Hicks, Rodney J.;
Donnelly, Paul S.

Publication type:

Article

Peptide Receptor Radionuclide Therapy with 67Cu-CuSarTATE is Highly Efficacious Against a Somatostatin Positive Neuroendocrine Tumor Model.

Published in:

Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.120.243543

By:

Cullinane, Carleen;
Jeffery, Charmaine M.;
Roselt, Peter D.;
van Dam, Ellen M.;
Jackson, Susan;
Kuan, Kevin;
Jackson, Price;
Binns, David;
Zuylekom, Jessica van;
Harris, Matthew J.;
Hicks, Rodney J.;
Donnelly, Paul S.

Publication type:

Article

Peptide Receptor Radionuclide Therapy with 67Cu-CuSarTATE is Highly Efficacious Against a Somatostatin Positive Neuroendocrine Tumor Model.

Published in:

Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.120.243543

By:

Cullinane, Carleen;
Jeffery, Charmaine M.;
Roselt, Peter D.;
van Dam, Ellen M.;
Jackson, Susan;
Kuan, Kevin;
Jackson, Price;
Binns, David;
Zuylekom, Jessica van;
Harris, Matthew J.;
Hicks, Rodney J.;
Donnelly, Paul S.

Publication type:

Article

Peptide Receptor Radionuclide Therapy with 67Cu-CuSarTATE is Highly Efficacious Against a Somatostatin Positive Neuroendocrine Tumor Model.

Published in:

Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.120.243543

By:

Cullinane, Carleen;
Jeffery, Charmaine M.;
Roselt, Peter D.;
van Dam, Ellen M.;
Jackson, Susan;
Kuan, Kevin;
Jackson, Price;
Binns, David;
van Zuylekom, Jessica;
Harris, Matthew J.;
Hicks, Rodney J.;
Donnelly, Paul S.

Publication type:

Article

Peptide Receptor Radionuclide Therapy with 67Cu-CuSarTATE is Highly Efficacious Against a Somatostatin Positive Neuroendocrine Tumor Model.

Published in:

Journal of Nuclear Medicine, 2020, v. 61, n. 6, p. 1, doi. 10.2967/jnumed.120.243543

By:

Cullinane, Carleen;
Jeffery, Charmaine M.;
Roselt, Peter D.;
van Dam, Ellen M.;
Jackson, Susan;
Kuan, Kevin;
Jackson, Price;
Binns, David;
Zuylekom, Jessica van;
Harris, Matthew J.;
Hicks, Rodney J.;
Donnelly, Paul S.

Publication type:

Article

Peptide Receptor Radionuclide Therapy with 67Cu-CuSarTATE is Highly Efficacious Against a Somatostatin Positive Neuroendocrine Tumor Model.

Published in:

Journal of Nuclear Medicine, 2020, v. 61, n. 5, p. 1, doi. 10.2967/jnumed.120.243543

By:

Cullinane, Carleen;
Jeffery, Charmaine M.;
Roselt, Peter D.;
van Dam, Ellen M.;
Jackson, Susan;
Kuan, Kevin;
Jackson, Price;
Binns, David;
van Zuylekom, Jessica;
Harris, Matthew J.;
Hicks, Rodney J.;
Donnelly, Paul S.

Publication type:

Article

Detection and therapy of neuroblastoma minimal residual disease using [64/67Cu]Cu-SARTATE in a preclinical model of hepatic metastases.

Published in:

EJNMMI Research, 2021, v. 11, n. 1, p. 1, doi. 10.1186/s13550-021-00763-0

By:

Dearling, Jason L. J.;
van Dam, Ellen M.;
Harris, Matthew J.;
Packard, Alan B.

Publication type:

Article

Mitochondrial mutations and metabolic adaptation in pancreatic cancer.

Published in:

Cancer & Metabolism, 2017, v. 5, p. 1, doi. 10.1186/s40170-017-0164-1

By:

Hardie, Rae-Anne;
van Dam, Ellen;
Cowley, Mark;
Ting-Li Han;
Balaban, Seher;
Pajic, Marina;
Pinese, Mark;
Iconomou, Mary;
Shearer, Robert F.;
McKenna, Jessie;
Miller, David;
Waddell, Nicola;
Pearson, John V.;
Grimmond, Sean M.;
Sazanov, Leonid;
Biankin, Andrew V.;
Villas-Boas, Silas;
Hoy, Andrew J.;
Turner, Nigel;
Saunders, Darren N.

Publication type:

Article

Copper-67-Labeled Bombesin Peptide for Targeted Radionuclide Therapy of Prostate Cancer.

Published in:

Pharmaceuticals (14248247), 2022, v. 15, n. 6, p. 728, doi. 10.3390/ph15060728

By:

Huynh, Truc T.;
van Dam, Ellen M.;
Sreekumar, Sreeja;
Mpoy, Cedric;
Blyth, Benjamin J.;
Muntz, Fenella;
Harris, Matthew J.;
Rogers, Buck E.

Publication type:

Article

Decreased Expression of zeta Molecules by T Lymphocytes Is Correlated with Disease Progression in...

Published in:

Journal of Infectious Diseases, 1999, v. 180, n. 3, p. 649, doi. 10.1086/314941

By:

Geertsma, Minke F.;
Wengen-Stevenhagen, Annelies van;
van Dam, Ellen M.;
Risberg, Karianne;
Kroon, Frank P.;
Groeneveld, Paul H.P.;
Nibbering, Peter H.

Publication type:

Article

From trainees to trainers to instructors: Sustainably building a national capacity in bioinformatics training.

Published in:

PLoS Computational Biology, 2019, v. 15, n. 6, p. 1, doi. 10.1371/journal.pcbi.1006923

By:

McGrath, Annette;
Champ, Katherine;
Shang, Catherine A.;
van Dam, Ellen;
Brooksbank, Cath;
Morgan, Sarah L.

Publication type:

Article

Reproducibility of goniometric measurement of the knee in the in-hospital phase following total knee arthroplasty.

Published in:

BMC Musculoskeletal Disorders, 2007, v. 8, p. 83, doi. 10.1186/1471-2474-8-83

By:

Lenssen, Anton F.;
van Dam, Ellen M.;
Crijns, Yvonne H. F.;
Verhey, Mark;
Geesink, Ruud J. T.;
van den Brandt, Piet A.;
de Bie, Rob A.

Publication type:

Article

Works by van Dam, Ellen

Identification and Characterisation of the RalA-ERp57 Interaction: Evidence for GDI Activity of ERp57.

45-Hour continuous quintuple-site actimetry: Relations between trunk and limb movements and effects of circadian sleep-wake rhythmicity.

Therapeutic Efficacy of a Bivalent Inhibitor of Prostate-Specific Membrane Antigen Labeled with <sup>67</sup>Cu.

Therapeutic Efficacy of a Bivalent Inhibitor of Prostate-Specific Membrane Antigen Labeled with Copper-67.

Peptide Receptor Radionuclide Therapy with <sup>67</sup>Cu-CuSarTATE is Highly Efficacious Against a Somatostatin Positive Neuroendocrine Tumor Model.

Therapeutic Efficacy of a Bivalent Inhibitor of Prostate-Specific Membrane Antigen Labeled with Copper-67.

Peptide Receptor Radionuclide Therapy with <sup>67</sup>Cu-CuSarTATE is Highly Efficacious Against a Somatostatin Positive Neuroendocrine Tumor Model.

Therapeutic Efficacy of a Bivalent Inhibitor of Prostate-Specific Membrane Antigen Labeled with Copper-67.

Peptide Receptor Radionuclide Therapy with <sup>67</sup>Cu-CuSarTATE is Highly Efficacious Against a Somatostatin Positive Neuroendocrine Tumor Model.

Peptide Receptor Radionuclide Therapy with <sup>67</sup>Cu-CuSarTATE is Highly Efficacious Against a Somatostatin Positive Neuroendocrine Tumor Model.

Peptide Receptor Radionuclide Therapy with <sup>67</sup>Cu-CuSarTATE is Highly Efficacious Against a Somatostatin Positive Neuroendocrine Tumor Model.

Peptide Receptor Radionuclide Therapy with <sup>67</sup>Cu-CuSarTATE is Highly Efficacious Against a Somatostatin Positive Neuroendocrine Tumor Model.

Peptide Receptor Radionuclide Therapy with 67Cu-CuSarTATE is Highly Efficacious Against a Somatostatin Positive Neuroendocrine Tumor Model.

Detection and therapy of neuroblastoma minimal residual disease using [64/67Cu]Cu-SARTATE in a preclinical model of hepatic metastases.

Mitochondrial mutations and metabolic adaptation in pancreatic cancer.

Copper-67-Labeled Bombesin Peptide for Targeted Radionuclide Therapy of Prostate Cancer.

Decreased Expression of zeta Molecules by T Lymphocytes Is Correlated with Disease Progression in...

From trainees to trainers to instructors: Sustainably building a national capacity in bioinformatics training.

Reproducibility of goniometric measurement of the knee in the in-hospital phase following total knee arthroplasty.